重编程瘤微环境:Calebin A作为控制结肠直肠癌炎症,干部和抵抗的多基模式转变
Abdullah A Alshehri1, Wael Y Khawagi1
1Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia.
Drug development research
|January 28, 2026
概括
卡莱宾A是一种来自Curcuma longa的多,向瘤微环境 (TME) 打击结肠直肠癌 (CRC). 它抑制关键途径,逆转多药性耐药性 (MDR),并显示出更广泛的癌症治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 结肠直肠癌 (CRC) 是癌症死亡的主要原因,由炎症,癌症干和多药性耐药性 (MDR) 驱动.
- 瘤微环境 (TME) 通过NF-κB激活和细胞交叉交谈在CRC进展中发挥着关键作用.
- 目前的治疗策略面临着克服TME介导耐药性的挑战.
研究的目的:
- 审查Calebin A (CA) 作为在癌症治疗中重编程TME的新型多目标剂的机制证据.
- 评估CA的分子标,信号通路,以及临床翻译的潜在挑战.
- 探索CA在结直肠癌之外的潜力.
主要方法:
- 在体外,外生和3DTME模型的文献整合.
- 对CA与NF-κB (p65) 和IKKβ等分子标的直接相互作用的分析.
- 评估CA对下游信号通路和细胞过程的影响,包括细胞亡和耐药性.
主要成果:
- CA直接抑制NF-κB和IKKβ的激活,减少MMP-9,CXCR4,β1-整蛋白和癌症干细胞 (CSC) 标记物的表达.
- CA通过caspase-3激活诱导亡,并通过正常化氧化还原平衡和增强化学敏感性来逆转MDR.
- CA调节STAT3,Wnt/β-catenin和PI3K/Akt通路,表明了广泛的微环境重编程潜力.
结论:
- 卡莱宾A通过恢复TME平衡来提供一种新的多治疗癌症的方法.
- 通过纳米技术和组合疗法克服生物可用性问题对于临床转化至关重要.
- 在癌症管理中,CA 作为下一代生态疗法的原型.
相关概念视频
02:17The Tumor Microenvironment
7.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K
02:40Cancer Stem Cells and Tumor Maintenance
6.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:38Inflammation
62.0K
Overview
62.0K
02:33Combinatorial Gene Control
9.6K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
9.6K
01:13Induced Pluripotent Stem Cells
28.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K